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Summary Biventricular resynchronization has been shown to be beneﬁcial on morbidity and
mortality in patients with symptomatic (NYHA class III or IV) systolic heart failure (left ventric-
ular ejection fraction or LVEF is less or equal to 35%) under optimal medical treatment with
electrical asynchrony (QRS≥ 120ms) and in sinus rhythm. The purpose of this study was to eval-
uate the efﬁcacy and safety of upgrading to biventricular resynchronization in paced patients
presenting with symptomatic systolic heart failure. Over a period of eight years, 24 paced
patients with symptomatic (class III or IV) systolic heart failure (LVEF≤ 35%) with electrical
asynchrony (QRS≥ 160ms) received an additional left ventricular pacing lead and a biventricu-
lar pulse generator. We compared the functional symptoms, QRS duration, LVEF, left ventricle
telediastolic diameter and any aggravation or onset of ventricular arrhythmia before and after
biventricular resynchronization. Biventricular resynchronization led to an improvement in dys-
pnea in 80% of cases (one or more class decrease on NHYA scale), a signiﬁcant shortening in
QRS duration (−40ms, p < 0.05), a signiﬁcant improvement in left ventricular dilation (−4mm,
p < 0.05) and a signiﬁcant improvement in the ejection fraction (+4%, p < 0.05). This study
showed that in paced patients presenting with cardiac failure and systolic dysfunction refrac-
tory to medical treatment, upgrading from a conventional pacing system to a biventricular
pacemaker leads to a signiﬁcant improvement in functional symptoms.
© 2008 Elsevier Masson SAS. All rights reserved.
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MOTS CLÉS
Resynchronisation ;
Stimulateur
cardiaque ;
Insufﬁsance
cardiaque ;
Amélioration
fonctionnelle
implantés d’un stimulateur cardiaque et présentant une insufﬁsance cardiaque avec dysfonc-
tion systolique et rebelle au traitement médical, la resynchronisation entraîne une amélioration
signiﬁcative de la symptomatologie fonctionnelle.
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ntroduction
he Multisite Stimulation in Cardiac insufﬁciency (Mustic)
1], Mulitcenter Insync Randomized Clinical Evaluation (Mir-
cle) [2] and Cardiac Resynchronization in Heart Failure
CARE-HF) [3] clinical trials have shown that, in patients pre-
enting with symptomatic heart failure (NYHA class III and
V) with left systolic ventricular dysfunction (left ventricular
jection fraction [LVEF] greater or equal to 35%), electrical
synchrony (QRS≥ 120ms) and sinus rhythm, cardiac pacing
ith biventricular resynchronization yielded signiﬁcant ben-
ﬁts in terms of alleviation of symptoms (dyspnea) [1,2], and
bove all in overall mortality [3] in comparison to patients
eceiving optimal pharmacological treatment only.
The populations enrolled in these different studies did
ot include previously paced patients receiving permanent
ight ventricular stimulation, although this type of stimula-
ion can induce or exacerbate interventricular asynchronism
4]. Thus, in patients presenting with left ventricular dys-
unction, right ventricle stimulation can alter both diastolic
nd systolic ventricular function. This was recently con-
rmed by the David study [5], which showed that the risks
f hemodynamic deterioration and mortality were higher in
eart failure patients receiving traditional cardiac stimula-
ion.
The aim of this study is to evaluate the functional efﬁcacy
nd safety of biventricular resynchronization in previously
aced patients.
ethodstudy
he objective of this single-centre, retrospective study was
o evaluate the effects of ventricular resynchronization in
atients, who received a pacemaker for a conventional
B
B
a
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ardiac stimulation indication, and who had subsequently
ndergone biventricular resynchronization in addition to this
onventional stimulation.
nclusion criteria
he inclusion criteria were as follows:
symptomatic cardiac failure (NYHA class III—IV) despite
medical treatment including at least two of the three fol-
lowing types of medicinal product at their optimal doses
(individual tolerance) for each patient:
◦ diuretic,
◦ ACE-inhibitors,
◦ beta blockers;
LVEF≤ 35%;
right ventricular paced-dependent patients;
ventricular asynchronism deﬁned by electrical asynchrony
deﬁned as a QRS width greater or equal to 160ms.
xclusion criteria
atients were excluded from this study for the following
easons:
hypertrophic or restrictive cardiomyopathy;
acute myocarditis;
history of acute coronary syndrome in the three months
preceding biventricular resynchronization;
arterial hypertension refractory to medical treatment;
history of cardiogenic shock in the week prior implanta-
tion;
non-dependent paced patients.S. Lemoine et al.
Résumé La resynchronisation biventriculaire a démontré son bénéﬁce en termes de morbid-
ité et de mortalité chez les patients en insufﬁsance cardiaque systolique (fraction d’éjection
ventriculaire gauche [FEVG] inférieur ou égal à 35 %) symptomatique (classe III et IV de la NYHA)
sous traitement médical optimal avec asynchronisme électrique (QRS≥ 120ms) et en rythme
sinusal. Notre travail vise à évaluer l’efﬁcacité et la tolérance de la resynchronisation biventric-
ulaire chez les patients déjà implantés de pacemaker et présentant une insufﬁsance cardiaque
systolique symptomatique. Sur une période de huit ans, 24 patients déjà implantés d’un pace-
maker en insufﬁsance cardiaque systolique (FEVG≤ 35%) symptomatique (classe III et IV) avec
asynchronisme électrique (QRS≥ 140ms) ont bénéﬁcié de l’implantation d’une sonde de stimu-
lation ventriculaire gauche avec changement concomitant de leur boîtier. Nous avons comparé
la symptomatologie fonctionnelle, la durée du QRS, la FEVG, le diamètre télédiastolique du
ventricule gauche et l’aggravation éventuelle ou l’apparition d’arythmie ventriculaire avant
et après resynchronisation biventriculaire. La stimulation biventriculaire s’accompagne d’une
amélioration de la dyspnée dans 80 % des cas (diminution d’un stade ou plus de la NYHA),
d’un raccourcissement signiﬁcatif de la durée du QRS (−40ms, p < 0,05), d’ une régression
signiﬁcative de la dilatation ventriculaire gauche (−4mm, p < 0,05) et d’une amélioration signi-
ﬁcative de la fraction d’éjection (+4 %, p < 0,05). Cette étude montre que chez les patients déjàiventricular stimulation programming
iventricular resynchronization was achieved by implanting
left ventricular lead in the coronary sinus via a lateral or
ostero-lateral coronary vein. Any patients in sinus rhythm
607
Table 1 Description of the characteristics of the
population.
Variable n % Mean (standard
deviation)
Age 75 (8)
Men 19 79
NYHA III 20 83
NYHA IV 4 17
Rhythm
Sinus 13 54
AF 11 46
HIS ablation 4 17
LVEF 27% (6)
Treatment
ACE inhibitors
and/or ARA II
24 100
Diuretics 22 91
Betablockers 20 83
Digitalis 3 13
Anti-aldosterone 7 30
ARA II: angiotensin II receptor antagonist; AF: atrial ﬁbrillation;
LVEF: left ventricular ejection fraction; HIS: bundle of HIS; ACE
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with a dual chamber pacemaker had their device replaced
with a conventional triple chamber pacemaker and the right-
ventricle-left ventricle interval was set, whenever possible,
at the nominal value (0ms). In the event of chronic atrial
ﬁbrillation, a conventional dual chamber pacemaker was
used with the left ventricular lead connected in the atrial
channel and the right ventricular lead connected in the
ventricular channel. In such patients, the atrioventricular
interval was set at its minimum value (< 20ms) so that the
two ventricles were stimulated in a synchronized fashion (LV
20ms ahead of RV) without recourse to cardiac ultrasound
programming.
Evaluation of patients
The patients were assessed both before and after biven-
tricular resynchronization (with no minimum or maximum
interval after resynchronization) on the basis of the ﬁve
following criteria:
• the primary assessment criterion was the functional symp-
toms;
• duration of QRS before and after resynchronization, and
thus changes in QRS width;
• LVEF evaluated by cardiac ultrasound;
• left ventricular telediastolic diameter evaluated by car-
diac ultrasound;
• onset or aggravation of ventricular arrhythmias and mor-
tality at the time the data were collected in May 2007.
Statistical analysis
Data analysis consisted of:
• a description of the characteristics of the study pop-
ulation. The qualitative variables were described by
percentages, and the quantitative variables by the mean,
standard deviation and minimum and maximum values;
• and a comparison of the parameters recorded before and
after resynchronization via a t-test for paired series. The
alpha risk was set at 5%.
Statistical analyses were performed using SAS v9.1 soft-
ware.
Results
Description of the study population
A total of 24 patients were included in the study with a
mean follow-up time of 26 months (range: 1—108 months).
Details of the population are provided in Table 1. There were
19 men and ﬁve women with a mean age of 75± 8 years
(range: 52—86). All patients presented with severe cardiac
failure with grade III and IV dyspnea in 83% and 17% of cases,
respectively.
Over half of the patients (13/24) were in sinus rhythm
while the remaining 11 (46%) were in permanent atrial ﬁb-
rillation (AF). Of these 11 patients, four had undergone His
bundle ablation. LVEF was 27± 6% (ranging from 15 to 35).
ACE-inhibitors and/or angiotensin II receptor antagonists
were prescribed in 100%, beta-blockers in 83%, diuretics in
91%, digitalis in 13% and anti aldosterones in 30% of patients.
M
F
c
iinhibitors: angiotensin-converting enzyme inhibitors.
ffects of biventricular pacing
he effects of biventricular pacing on the primary and sec-
ndary endpoints are summarized in Tables 2a and 2b.
rimary assessment criterion
iventricular resynchronization led to an improvement in
unctional status with a decrease of one or two NYHA class
n 20 out of the 24 patients (80%).
econdary assessment criteria
RS duration was shortened by a mean of 40ms (stan-
ard deviation of 20ms), decreasing from 180ms before
esynchronization to 140ms afterwards (p < 0.0001) with a
ean concomitant reduction in left ventricular diastolic
iameter of 4mm (standard deviation of 7mm) (p = 0.02)
nd a 4% increase in LVEF (standard deviation of 9%)
p = 0.045).
During the follow-up period, four patients exhibited ven-
ricular arrhythmias, i.e., ventricular premature beats in
wo, ventricular tachycardia (VT) in one, VT which was well
olerated and resolved spontaneously and well tolerated
low VT mimicking an accelerated idiopathic ventricular
hythm in one. These two VT episodes were retrieved
rom the pacemaker Holter memories. Three of these four
atients did not present with any improvement in their LVEF
uring follow-up.ortality
our patients died during follow-up: two from unrecorded
auses, one from mechanical valve thrombosis related to
nappropriate anticoagulation therapy, and one from refrac-
608 S. Lemoine et al.
Table 2a Changes in dyspnea before and after resynchronization.
Dyspnea after resynchronization
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IV
ory heart failure. The intervals between implantation and
eath were seven, eight, ﬁve and seven years respectively.
iscussion
his retrospective study evaluating the effects of biven-
ricular resynchronization in patients previously implanted
ith a pacemaker for a conventional indication and present-
ng with symptomatic refractory heart failure and electrical
synchrony, shows that adding a left ventricular lead is asso-
iated with a functional improvement. In these patients,
iventricular resynchronization signiﬁcantly reduced the
RS duration and the left ventricular end diastolic diame-
er. It also led to a signiﬁcant increase in the left ventricular
jection fraction. These positive results should be offset
gainst the onset or exacerbation of ventricular arrhythmias
n 20% of cases, although these were well tolerated.
The Mustic and Miracle studies had already demonstrated
he beneﬁts of biventricular resynchronization on func-
ional criteria. The positive effects of resynchronization
ave since been conﬁrmed in numerous studies. Bradley’s
eta-analysis [6] evidenced a 30% decrease in the number
f hospitalizations for cardiac failure after implantation of
multisite pacemaker. The positive impact on the num-
er of hospitalizations for heart failure tends to indicate
hat resynchronization could be of major medical-economic
alue since hospitalizations for heart failure are believed to
epresent 60% of the expenditure related to this condition
7].
Recently, the CARE HF study showed that atrio-
iventricular resynchronization also led to reduced mortal-
ty in comparison to optimal medical treatment. However,
ll the paced patients enrolled in these studies were in sinus
hythm and one of the inclusion criteria was the absence of
pre-existing pacemaker and/or absence of an indication
or permanent cardiac pacing.
The RD-CHF study [8] was the ﬁrst randomized, prospec-
ive study with a cross-over design to assess the effects
f biventricular resynchronization in permanently paced
f
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Table 2b Comparison of parameters before and after resynch
Parameters Before mean (S.D.) After mean
VO2max 15 (3) 17 (6)
LVTD 68 (11) 64 (9)
QRS duration 0.18 (0.04) 0.14 (0.03)
LVEF 27 (7) 31 (11)
LVTD: left ventricular telediastolic dilation; LVEF: left ventricular ejec
VO2max : maximum oxygen consumption.18 (75%) 1 (4%) 1 (4%)
1 (4%) 1 (4%) 2 (8%)
atients. The 56 patients enrolled in this single-center
tudy presented with advanced, symptomatic heart fail-
re (NYHA class III and IV) under optimal medical therapy,
nd mechanical asynchronism evidenced on the cardiac
ltrasound examination. Three months of right ventricu-
ar stimulation alone were compared with three months of
iventricular stimulation (cross-over after three months).
he results showed an improvement in the functional symp-
oms and signs of heart failure, a reduction in QRS duration
nd above all a decrease in the number of patients requir-
ng hospitalization for heart failure with biventricular pacing
s compared to permanent right ventricular pacing alone.
hese results match the ﬁndings of our study, with the
xception of the decrease in hospitalizations which was not
valuated in this study.
The beneﬁts of resynchronization in paced patients were
lso evidenced in the study conducted by Eldadah et al. [9]
ho used tissue Doppler and strain rate imaging to assess
eft ventricular systolic function in 12 patients as well as
n the study by Marai et al. [10]. In the Marai study, 98
atients with refractory heart failure were divided into
wo groups: 25 patients with right ventricular apical pacing
ere upgraded to cardiac resynchronization therapy and 73
atients received de novo resynchronization therapy. The
eneﬁts of resynchronization were at least equal in the two
roups. Finally, a recent study by Laurenzi et al. [11] con-
rmed the beneﬁts of biventricular upgrading in patients
ith a conventional pacing system in terms of improvement
n symptoms and inverse remodeling.
Almost half the patients enrolled in this study presented
ith permanent AF. Data on biventricular resynchroniza-
ion for AF are limited. The Mustic AF study enrolled 48
atients with permanent AF and slow ventricular conduc-
ion and compared right ventricular apical pacing (VVIR
ode) to biventricular pacing (BIV VVIR). An improvement inunctional symptoms was observed after upgrading to biven-
ricular pacing versus conventional pacing. The mean six
inute walk distance was increased by 32 meters (p < 0.05)
nd a 13% increase in the VO2max peak (p < 0.05) was also
bserved. On the other hand, biventricular pacing was not
ronization.
(S.D.) Before-after mean (S.D.) p
−4.4 (2) 0.06
4.6 (7) 0.02
−0.04 (0.02) < 0.0001
−4.3 (9) 0.045
tion fraction; p: degree of signiﬁcance; S.D.: standard deviation;
R[
[
[Resynchronization and pacemaker
correlated with a decrease in the number of hospitalizations
or in mortality. The ﬁndings of the Mustic AF study were
further conﬁrmed by the Pave study [12] which compared
biventricular resynchronization to right ventricular pacing
alone in patients who had undergone His-bundle for rapid
permanent atrial ﬁbrillation. Like in the Mustic AF study,
the Pave study demonstrated a functional improvement in
the biventricular group.
In this study, resynchronization was associated with the
onset of ventricular arrhythmias in four patients. This dele-
terious effect of resynchronization on heart rhythm was not
reported in the RD-CHF [8] or Contak CD [13] studies. A pos-
sible explanation for this difference could be the lack of
any improvement in the LVEF which remained below 30%
after resynchronization in three out of four patients who
developped ventricular arrhythmias. Rather than a delete-
rious effect of resynchronization, this phenomenon could
be explained by the natural progression of left ventricular
dysfunction in non responding patients.
Study limitations
There are several limitations in this study. In addition to its
retrospective and non comparative design, there is a selec-
tion bias, since only patients in whom resynchronization was
possible were included. In addition, the statistical power
of the study is reduced due to the small study population.
Its retrospective nature highlighted the fact that data were
incomplete for some patients. Finally, it would have been
interesting to perform a sub-group analysis in patients who
had undergone His-bundle ablation for permanent atrial ﬁb-
rillation. This was not impossible due to the small number
of patients enrolled.
Conclusion
Despite its limitations, this study shows that in previously
paced patients presenting with heart failure-refractory to
optimal medical treatment and decrease left ventricular
function upgrading to biventricular pacing is associated with
an improvement in functional symptoms. This positive effect
of resynchronisation is not only obtained in patients who
are in sinus rhythm but also in AF patients. It can there-
fore be proposed as an effective therapeutic option for the
treatment of this type of patient.
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